These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
941 related items for PubMed ID: 34238294
1. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents. Zhu Y, Liu K, Chen M, Liu Y, Gao A, Hu C, Li H, Zhu H, Han H, Zhang J, Zhao Y. Cardiovasc Diabetol; 2021 Jul 08; 20(1):137. PubMed ID: 34238294 [Abstract] [Full Text] [Related]
2. The association between the triglyceride-glucose index and in-stent restenosis in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Jiang H, Liu Y, Guo H, Liu Z, Li Z. BMC Cardiovasc Disord; 2024 May 03; 24(1):234. PubMed ID: 38702615 [Abstract] [Full Text] [Related]
3. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China. Hu C, Zhang J, Liu J, Liu Y, Gao A, Zhu Y, Zhao Y. Cardiovasc Diabetol; 2020 Jul 23; 19(1):116. PubMed ID: 32703284 [Abstract] [Full Text] [Related]
7. Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective study. Xie F, Yu Z, Xiong Y, Wu Z, Wu Y. Eur J Med Res; 2024 Feb 26; 29(1):145. PubMed ID: 38409069 [Abstract] [Full Text] [Related]
8. The predictive value of the triglyceride glucose index combined with cystatin C for the prognosis of patients with acute coronary syndrome. Wang C, Liao P, Tang C, Chen C, Zhang X. Front Endocrinol (Lausanne); 2024 Feb 26; 15():1423227. PubMed ID: 39257901 [Abstract] [Full Text] [Related]
9. Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome. Chen Q, Xiong S, Ye T, Gao Y, Wang J, Li X, Li Y, Cui C, Liu H, Zhang Z, Cai L, Zheng J. Cardiovasc Diabetol; 2024 May 16; 23(1):172. PubMed ID: 38755609 [Abstract] [Full Text] [Related]
10. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up. Zhao LP, Xu WT, Wang L, Li H, Shao CL, Gu HB, Chan SP, Xu HF, Yang XJ. Coron Artery Dis; 2015 Jan 16; 26(1):5-10. PubMed ID: 25211654 [Abstract] [Full Text] [Related]
11. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study. Zhao X, Wang Y, Chen R, Li J, Zhou J, Liu C, Zhou P, Sheng Z, Chen Y, Song L, Zhao H, Yan H. Cardiovasc Diabetol; 2021 Jun 28; 20(1):131. PubMed ID: 34183007 [Abstract] [Full Text] [Related]
12. High triglyceride-glucose index is associated with poor cardiovascular outcomes in Chinese acute coronary syndrome patients without diabetes mellitus who underwent emergency percutaneous coronary intervention with drug-eluting stents. Zhang Y, Chu C, Zhong Z, Luo YB, Ning FF, Guo N. Front Endocrinol (Lausanne); 2023 Jun 28; 14():1101952. PubMed ID: 36875470 [Abstract] [Full Text] [Related]
17. Atherogenic Index of Plasma and the Risk of In-Stent Restenosis in Patients with Acute Coronary Syndrome beyond the Traditional Risk Factors. Zhu Y, Chen M, Liu K, Gao A, Kong X, Liu Y, Han H, Li H, Zhu H, Zhang J, Zhao Y. J Atheroscler Thromb; 2022 Aug 01; 29(8):1226-1235. PubMed ID: 34497172 [Abstract] [Full Text] [Related]